Table 3

Distributions (%) of different phenotypes by combinations of different serotonergic and adrenergic genotype. n refers to number of people (patients and controls) with a specified genotype or genotype combination

nSLC 6A4α2C Del 322–325α2A −1291 (C→G)Controls (%)IBS-C (%)IBS-D (%)IBS-Alt (%)CAP (%)
Wt, wild-type; Het, heterozygous; hom, homozygous polymorphism.
IBS-C, irritable bowel syndrome with predominant constipation; IBS-D, irritable bowel syndrome with predominant diarrhoea; IBS-Alt, irritable bowel syndrome with alternating bowel function; CAP, chronic abdominal pain.
58WtWtWt312428125
59WtWtHet/hom242732107
9WtHet/homWt22443300
7WtHet/homHet/hom29042290
126Het/homWtWt36133795
103Het/homWtHet/hom31253275
12Het/homHet/homWt25342588
11Het/homHet/homHet/hom184618180